Altimmune Ownership | Who Owns Altimmune?


OverviewForecastRevenueFinancialsChartTranscripts

Altimmune Ownership Summary


Altimmune is owned by 12.78% institutional investors, 0.71% insiders, and 86.50% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.85% of ALT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.36% of its assets in Altimmune shares.

ALT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAltimmune12.78%0.71%86.50%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.70M10.85%$35.03M
Vanguard group9.49M10.61%$34.26M
State street3.60M4.42%$13.58M
Tang capital management2.13M2.62%$8.04M
Geode capital management2.29M2.56%$8.28M
Two sigma investments, lp2.00M2.45%$7.53M
Jane street group1.78M2.00%$6.44M
Two sigma advisers, lp1.43M1.75%$5.39M
Morgan stanley1.36M1.52%$4.91M
Goldman sachs group1.35M1.51%$4.87M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knoll capital management1.12M2.27%$4.23M
Beirne wealth consulting services376.46K0.39%$1.36M
Tang capital management2.13M0.31%$8.04M
Brown wealth management258.67K0.25%$933.81K
Wealth effects111.75K0.13%$403.42K
Caitong asset management12.32K0.12%$44.48K
Summit financial wealth advisors103.29K0.05%$372.87K
Sherbrooke park advisers15.90K0.03%$59.96K
Hennion & walsh asset management214.63K0.03%$774.82K
Axq capital, lp25.70K0.02%$92.78K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de9.70M0.00%3.33M
Vanguard group9.49M0.00%3.12M
Two sigma investments, lp2.00M0.01%1.56M
Jane street group1.78M0.00%1.50M
Two sigma advisers, lp1.43M0.01%1.30M

Top Sellers

HolderShares% AssetsChange
Bellevue group---1.06M
Schroder investment management group---961.88K
Caption management130.00K0.00%-850.78K
Capital fund management---726.83K
Tang capital management2.13M0.31%-618.69K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management476.93K0.00%476.93K$1.80M
Jump financial115.80K0.01%115.80K$436.57K
Alps advisors85.68K0.00%85.68K$309.29K
Bridgeway capital management50.60K0.00%50.60K$190.76K
Engineers gate manager lp41.04K0.00%41.04K$154.73K

Sold Out

HolderChange
Capital performance advisors llp-11.00
Twin peaks wealth advisors-13.00
Tradewinds capital management-20.00
Principal securities-35.00
Quantbot technologies lp-60.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202550-72.38%11,431,385-72.45%120.49%32-63.22%4-91.67%
Sep 30, 202562-69.46%8,979,026-74.79%110.58%26-77.39%19-50.00%
Jun 30, 20252077.81%37,429,392-1.85%451.80%11540.24%39-29.09%
Mar 31, 20257-96.55%2,264,429-94.40%20.09%2-98.15%2-95.12%
Dec 31, 20241978.84%39,287,627-0.54%551.79%10425.30%41-4.65%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.58M3.36%-
State Street® SPDR® S&P® Biotech ETF3.36M2.68%-18.06K
Vanguard Total Stock Mkt Idx Inv3.28M2.62%-
iShares Russell 2000 ETF2.11M1.69%2.11M
SPDR® S&P Biotech ETF1.24M1.41%2.77K
Vanguard Strategic Equity Inv1.57M1.26%578.46K
CT (Lux) American Smaller Com 9U USD830.56K1.08%-2.54M
Vanguard Institutional Extnd Mkt Idx Tr1.15M0.92%5.92K
Bellevue Healthcare Ord600.00K0.84%600.00K
Nuveen Quant Small Cap Equity R61.02M0.81%1.02M

Recent Insider Transactions


DateNameRoleActivityValue
Mar 06, 2026WEAVER GREGORY L Chief Financial OfficerBuy$17.70K
Mar 06, 2026Durso Jerome Benedict President and CEOBuy$70.79K
Jan 08, 2026Pisano Wayne-Buy$20.41K
Jan 05, 2026Sohn Catherine A.-Buy$2.12K
Dec 29, 2025Jorkasky Diane-Buy$2.00K

Insider Transactions Trends


DateBuySell
2026 Q12-
2025 Q43-
2025 Q3--
2025 Q12-
2024 Q4--

ALT Ownership FAQ


Who Owns Altimmune?

Altimmune shareholders are primarily institutional investors at 12.78%, followed by 0.71% insiders and 86.51% retail investors. The average institutional ownership in Altimmune's industry, Biotech Stocks , is 381.47%, which Altimmune falls below.

Who owns the most shares of Altimmune?

Altimmune’s largest shareholders are Blackrock funding, inc. /de (9.7M shares, 10.85%), Vanguard group (9.49M shares, 10.61%), and State street (3.6M shares, 4.42%). Together, they hold 25.89% of Altimmune’s total shares outstanding.

Does Blackrock own Altimmune?

BlackRock is not among the top 10 institutional shareholders of Altimmune.

Who is Altimmune’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Altimmune’s biggest shareholder by percentage of total assets invested, with 2.27% of its assets in 1.12M Altimmune shares, valued at 4.23M$.

Who is the top mutual fund holder of Altimmune shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Altimmune shares, with 3.36% of its total shares outstanding invested in 2.58M Altimmune shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools